We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLYVK:NASDAQLiberty Live Holdings, Inc. - Series C Liberty Live Group Analysis

Data as of 2026-05-19 - not real-time

$96.42

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Liberty Live Holdings trades at $96.42, comfortably above its 20‑day ($95.47) and 50‑day ($95.59) moving averages, and the bullish MACD (line $0.89 above signal $0.57) signals short‑term momentum. The RSI sits at a neutral 50.3 and volume is on an upward trend, while the stock sits midway between a support level of $90.55 and resistance near $101.83, suggesting room for upside. Revenue growth is strong at 35% YoY, yet profitability is weak—gross margin is only 20%, operating margin is –26%, and trailing EPS is –$3.83, resulting in negative PE and PB multiples. The balance sheet shows $1.82 B of debt against $524 M of cash, and a negative book value per share ($‑3.45), flagging financial risk. Despite these fundamentals, market sentiment is highly positive (Fear‑Greed Index 89 – “Extreme Greed”) and analysts project a target price of $115, implying a 19% upside.
Investors should weigh the technical bullishness and growth narrative against the heavy debt load, negative earnings, and high 30‑day volatility (33%) before deciding on position size.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and price above short‑term SMAs
  • Increasing volume indicating buying interest
  • Proximity to support level provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth (35% YoY) and analyst target price of $115
  • Technical upside to resistance at $101.83
  • Market sentiment in extreme greed phase supporting price rally

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt burden and negative equity raise solvency concerns
  • Sustained negative earnings and cash flow
  • Potential for turnaround if operating margins improve

Key Metrics & Analysis

Financial Health

Revenue Growth35.20%
Profit Margin-88.23%
P/E Ratio-33.7
ROA-2.05%
P/B Ratio-27.9
Op. Cash Flow$-21615000
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI50.3
Support$90.55
Resistance$101.83
MA 20$95.47
MA 50$95.59
MA 200$90.78
MACDBullish
VolumeIncreasing
Fear & Greed Index89.18

Valuation

Target Price$115.00
Upside/Downside19.27%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.83
Volatility33.40%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.